3 glp 1 drugs More people with type diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness How GLP-1 medications are transforming

doi: 10.1038/s41591-019-0509-0 125 HeFFLiYM

Since most glucose-dependent insulinotropic polypeptide (GIP) receptor: glucagon-like peptide- 1 receptor (GLP- 1) receptor: glucagon receptor triagonists compete in efficacy with bariatric surgery, the success of these agents in preclinical models and clinical trials suggests a bright future for multi-agonists in the treatment of metabolic diseases

This enhanced effectiveness is related to the medicines'capacity to influence both peripheral and central pathways that govern energy balance

Bloating and Abdominal Distension: Individuals with gastroparesis frequently describe a sensation of bloating or a distended abdomen, creating discomfort and unease

doi: 10.1016/j.ejmech.2025.118163

Bushi, G